Center for Scientific Review; Notice of Closed Meetings, 28018-28019 [2020-10124]
Download as PDF
<![CDATA[
28018
Federal Register / Vol. 85, No. 92 / Tuesday, May 12, 2020 / Notices
operation of a student loan fund to
increase the number of qualified nurse
faculty.
Under the agreement, HRSA makes
awards to the school for the NFLP loan
fund, which must be maintained in a
distinct account. The school of nursing
makes loans from the NFLP account to
students enrolled full-time or, at the
discretion of the Secretary, part-time, in
a master’s or doctoral nursing education
program that will prepare them to
become qualified nursing faculty.
Following graduation from the NFLP
lending school, loan recipients may
receive up to 85 percent NFLP loan
cancellation over a four-year period in
exchange for service as full-time faculty
at a school of nursing. The NFLP
lending school collects any portion of
the loan that is not cancelled and any
loans that go into repayment due to
default, and deposits these monies into
the NFLP loan fund to make additional
NFLP loans.
The NFLP—Program Specific Data
Form is a required electronic attachment
within the NFLP application materials.
The data provided in the form is
essential for the formula-based criteria
used to determine the award amount to
the applicant schools. The form will
collect application related data from
applicants such as the amount
requested, number of students to be
funded, tuition information, and
projected unused loan fund balance.
Approval of the NFLP—Program
Specific Data Form will allow HRSA to
continue to efficiently capture data to
generate the formula-based awards for
the NFLP program. This data collection
assists HRSA in streamlining the
application submission process,
enabling an efficient award
determination process, and facilitating
reporting on the use of funds and
analysis of program outcomes.
HRSA is also seeking public comment
on the NFLP–APR Financial Data Form.
The NFLP–APR Financial Data Form is
an online form that exists in the HRSA
Electronic Handbooks (EHBs)
Performance Report module. The NFLP–
APR Financial Data Form will collect
outcome and financial data to capture
the NFLP loan fund account activity
related to financial receivables,
disbursements, and borrower account
data related to employment status, loan
cancellation, loan repayment and
collections. Participating schools will
provide HHS with current and
cumulative information on: (1) NFLP
loan funds received, (2) number and
amount of NFLP loans made, (3) number
and amount of loans cancelled, (4)
number and amount of loans in
repayment, (5) loan default rate percent,
(6) number of NFLP graduates employed
as nurse faculty, and (7) other related
loan fund costs and activities.
The school of nursing must keep
records of all NFLP loan fund
transactions. The NFLP–APR Financial
Data Form is used to monitor grantee
performance by collecting information
related to the NFLP loan fund
operations and financial activities for a
specified reporting period (July 1
through June 30 of the academic year).
Participating schools are required to
complete and submit the NFLP–APR
Financial Data Form annually.
The data provided in the form is
essential for HRSA to effectively
monitor the school’s use of NFLP funds
in accordance with the statute and
program guidelines. Approval of the
NFLP–APR Financial Data Form
extension will allow HRSA to continue
to monitor program performance and
program outcome.
Likely Respondents: Participating
NFLP schools and applicants to the
NFLP program.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install, and utilize
technology and systems for the purpose
of collecting, validating, and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
Number of
respondents per
respondent
Total burden
hours
Nurse Faculty Loan Program—Program Specific Data
Form .............................................................................
Nurse Faculty Loan Program—Annual Performance Report Financial Data Form .............................................
90
1
90
8
720
260
1
260
6
1,560
Total Burden ....................................................................
350
............................
350
........................
2,280
Maria G. Button,
Director, Executive Secretariat.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2020–10134 Filed 5–11–20; 8:45 am]
BILLING CODE 4165–15–P
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
jbell on DSKJLSW7X2PROD with NOTICES
Average
burden per
response
(in hours)
Total
responses
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
VerDate Sep<11>2014
18:47 May 11, 2020
Jkt 250001
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Vascular and
Hematology Integrated Review Group;
Hemostasis and Thrombosis Study Section.
Date: June 12, 2020.
Time: 8:00 a.m. to 6:00 p.m.
E:\FR\FM\12MYN1.SGM
12MYN1
jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 85, No. 92 / Tuesday, May 12, 2020 / Notices
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Dr., Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Ai-Ping Zou, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4118,
MSC 7814, Bethesda, MD 20892, 301–408–
9497, zouai@csr.nih.gov.
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group; Mechanisms of Cancer
Therapeutics—2 Study Section.
Date: June 15–16, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Dr., Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Careen K. Tang-Toth,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6214,
MSC 7804, Bethesda, MD 20892, (301)435–
3504, tothct@csr.nih.gov.
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group; Cancer Immunopathology and
Immunotherapy Study Section.
Date: June 17–18, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Dr., Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Denise R Shaw, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6158,
MSC 7804, Bethesda, MD 20892, 301–435–
0198, shawdeni@csr.nih.gov.
Name of Committee: Digestive, Kidney and
Urological Systems Integrated Review
Group;Hepatobiliary Pathophysiology Study
Section.
Date: June 17–18, 2020.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Dr., Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Jianxin Hu, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2156,
Bethesda, MD 20892, 301–827–4417,
jianxinh@csr.nih.gov.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience
Integrated Review Group; Somatosensory and
Pain Systems Study Section.
Date: June 17–18, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Dr., Bethesda,
MD 20892, (Virtual Meeting).
Contact Person: M. Catherine Bennett,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
VerDate Sep<11>2014
18:47 May 11, 2020
Jkt 250001
Health, 6701 Rockledge Drive, Room 5182,
MSC 7846, Bethesda, MD 20892, 301–435–
1766, bennettc3@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Community Level Health Promotion
and Behavior and Implementation Research.
Date: June 17, 2020.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Dr., Bethesda,
MD 20892 (Telephone Conference Call).
Contact Person: Preethy Nayar, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3156,
Bethesda, MD 20892, nayarp2@csr.nih.gov.
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group, Cellular
Aspects of Diabetes and Obesity Study
Section.
Date: June 17–18, 2020.
Time: 9:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Dr., Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Antonello Pileggi, MD,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6166,
Bethesda, MD 20892–7892, (301) 402–6297,
pileggia@csr.nih.gov.
Name of Committee: Population Sciences
and Epidemiology Integrated Review Group;
Neurological, Aging and Musculoskeletal
Epidemiology Study Section.
Date: June 17–18, 2020.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health
Rockledge II 6701 Rockledge Dr. Bethesda,
MD 20892 (Virtual Meeting)
Contact Person: Heidi B Friedman, Ph.D.
Scientific Review Officer Center for Scientific
Review National Institutes of Health 6701
Rockledge Drive, Room 1012A, MSC 7770
Bethesda, MD 20892 301–435–1721
hfriedman@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: May 7, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–10124 Filed 5–11–20; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
28019
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders;
Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the Communication
Disorders Review Committee, June 11,
2020, 08:00 a.m. to June 12, 2020, 05:00
p.m., Embassy Suites—Chevy Chase
Pavilion, 4300 Military Road NW,
Washington, DC 20015 which was
published in the Federal Register on
January 13, 2020, 85 FR 1816.
This notice is being amended to
change the meeting location from in
person to a virtual meeting. The meeting
is closed to the public.
Dated: May 7, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–10127 Filed 5–11–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory Child
Health and Human Development
Council. The meeting will be held as a
virtual meeting and is open to the
public as indicated below.
Individuals who plan to view the
virtual meeting and need special
assistance or other reasonable
accommodations, should notify the
Contact Person listed below in advance
of the meeting. The meeting will be
videocast and access instructions can be
found at https://www.nichd.nih.gov/
about/advisory/nachhd/virtual-meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications/
contract proposals and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the grant applications,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
E:\FR\FM\12MYN1.SGM
12MYN1
]]>Agencies
[Federal Register Volume 85, Number 92 (Tuesday, May 12, 2020)]
[Notices]
[Pages 28018-28019]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-10124]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Vascular and Hematology Integrated Review
Group; Hemostasis and Thrombosis Study Section.
Date: June 12, 2020.
Time: 8:00 a.m. to 6:00 p.m.
[[Page 28019]]
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Dr., Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ai-Ping Zou, MD, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4118, MSC 7814, Bethesda, MD
20892, 301-408-9497, [email protected].
Name of Committee: Oncology 2--Translational Clinical Integrated
Review Group; Mechanisms of Cancer Therapeutics--2 Study Section.
Date: June 15-16, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Dr., Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Careen K. Tang-Toth, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6214, MSC 7804, Bethesda, MD
20892, (301)435-3504, [email protected].
Name of Committee: Oncology 2--Translational Clinical Integrated
Review Group; Cancer Immunopathology and Immunotherapy Study
Section.
Date: June 17-18, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Dr., Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Denise R Shaw, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6158, MSC 7804, Bethesda, MD 20892, 301-435-
0198, [email protected].
Name of Committee: Digestive, Kidney and Urological Systems
Integrated Review Group;Hepatobiliary Pathophysiology Study Section.
Date: June 17-18, 2020.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Dr., Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jianxin Hu, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 2156, Bethesda, MD 20892, 301-827-4417,
[email protected].
Name of Committee: Integrative, Functional and Cognitive
Neuroscience Integrated Review Group; Somatosensory and Pain Systems
Study Section.
Date: June 17-18, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Dr., Bethesda, MD 20892, (Virtual Meeting).
Contact Person: M. Catherine Bennett, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5182, MSC 7846, Bethesda, MD
20892, 301-435-1766, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Community Level Health Promotion and
Behavior and Implementation Research.
Date: June 17, 2020.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Dr., Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Preethy Nayar, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3156, Bethesda, MD 20892, [email protected].
Name of Committee: Endocrinology, Metabolism, Nutrition and
Reproductive Sciences Integrated Review Group, Cellular Aspects of
Diabetes and Obesity Study Section.
Date: June 17-18, 2020.
Time: 9:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Dr., Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Antonello Pileggi, MD, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6166, Bethesda, MD 20892-7892,
(301) 402-6297, [email protected].
Name of Committee: Population Sciences and Epidemiology
Integrated Review Group; Neurological, Aging and Musculoskeletal
Epidemiology Study Section.
Date: June 17-18, 2020.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health Rockledge II 6701 Rockledge
Dr. Bethesda, MD 20892 (Virtual Meeting)
Contact Person: Heidi B Friedman, Ph.D. Scientific Review
Officer Center for Scientific Review National Institutes of Health
6701 Rockledge Drive, Room 1012A, MSC 7770 Bethesda, MD 20892 301-
435-1721 [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: May 7, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-10124 Filed 5-11-20; 8:45 am]
BILLING CODE 4140-01-P
